ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesE09.355

E09.355

Billable

Drug or chemical induced diabetes mellitus with stable proliferative diabetic retinopathy

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 E09.355 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with stable proliferative diabetic retinopathy.

Key Diagnostic Point:

E09.355 refers to diabetes mellitus that has been induced by drugs or chemicals, specifically characterized by the presence of stable proliferative diabetic retinopathy. This condition arises when certain medications or substances lead to an increase in blood glucose levels, resulting in diabetes. Proliferative diabetic retinopathy is a severe complication of diabetes, where abnormal blood vessels grow in the retina, potentially leading to vision loss. The term 'stable' indicates that the retinopathy has not progressed or worsened, which is crucial for management and treatment planning. Patients with this condition may require careful monitoring of their HbA1c levels, which reflect average blood glucose over the past two to three months, to ensure they remain within target ranges. Insulin management may be necessary, especially if the diabetes is severe or if oral medications are ineffective. Understanding the interplay between the inducing agent and the diabetic complications is essential for effective treatment and coding.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Identification of the specific drug or chemical causing diabetes
  • Differentiation between drug-induced diabetes and other types of diabetes
  • Assessment of the severity and stability of diabetic retinopathy
  • Monitoring and documentation of HbA1c levels

Audit Risk Factors

  • Inadequate documentation of the inducing drug or chemical
  • Failure to document the stability of diabetic retinopathy
  • Incorrect coding of diabetes type
  • Lack of HbA1c level documentation

Specialty Focus

Medical Specialties

Endocrinology

Documentation Requirements

Detailed history of diabetes onset, medication history, and current management plan.

Common Clinical Scenarios

Patients presenting with new-onset diabetes due to medication, requiring insulin therapy.

Billing Considerations

Ensure clear documentation of the drug responsible for diabetes and the management plan.

Ophthalmology

Documentation Requirements

Comprehensive eye examination findings, including retinal imaging results.

Common Clinical Scenarios

Patients with diabetes presenting for routine eye exams or with vision changes.

Billing Considerations

Document the stability of retinopathy and any interventions performed.

Coding Guidelines

Inclusion Criteria

Use E09.355 When
  • According to ICD
  • 10 guidelines, E09
  • 355 should be used when diabetes is specifically induced by a drug or chemical, and there is evidence of stable proliferative diabetic retinopathy
  • Coders must ensure that the documentation supports the diagnosis and that the retinopathy is stable

Exclusion Criteria

Do NOT use E09.355 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

99214CPT Code

Established patient office visit, level 4

Clinical Scenario

Used for follow-up visits for diabetes management.

Documentation Requirements

Document the patient's diabetes management plan, including medication adjustments and retinopathy assessment.

Specialty Considerations

Endocrinologists should ensure comprehensive documentation of diabetes control and complications.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of drug-induced diabetes, improving the accuracy of diabetes-related data and facilitating better patient management.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of drug-induced diabetes, improving the accuracy of diabetes-related data and facilitating better patient management.

Reimbursement & Billing Impact

reimbursement and quality reporting.

Resources

Clinical References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Coding & Billing References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Frequently Asked Questions

What types of drugs can induce diabetes?

Common drugs that can induce diabetes include corticosteroids, certain antipsychotics, and some medications used in cancer treatment. It is important to document the specific drug responsible for accurate coding.